352 related articles for article (PubMed ID: 32013155)
1. Small Molecules Targeting the Specific Domains of Histone-Mark Readers in Cancer Therapy.
Zhu H; Wei T; Cai Y; Jin J
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013155
[TBL] [Abstract][Full Text] [Related]
2. Bromodomain inhibitors and cancer therapy: From structures to applications.
Pérez-Salvia M; Esteller M
Epigenetics; 2017 May; 12(5):323-339. PubMed ID: 27911230
[TBL] [Abstract][Full Text] [Related]
3. Targeting non-bromodomain chromatin readers.
Arrowsmith CH; Schapira M
Nat Struct Mol Biol; 2019 Oct; 26(10):863-869. PubMed ID: 31582844
[TBL] [Abstract][Full Text] [Related]
4. Chemical inhibitors targeting histone methylation readers.
Huang X; Chen Y; Xiao Q; Shang X; Liu Y
Pharmacol Ther; 2024 Apr; 256():108614. PubMed ID: 38401773
[TBL] [Abstract][Full Text] [Related]
5. Bromodomain biology and drug discovery.
Zaware N; Zhou MM
Nat Struct Mol Biol; 2019 Oct; 26(10):870-879. PubMed ID: 31582847
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
7. Structure and mechanism of plant histone mark readers.
Liu R; Li X; Chen W; Du J
Sci China Life Sci; 2018 Feb; 61(2):170-177. PubMed ID: 29019143
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
Biswas S; Rao CM
Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
[TBL] [Abstract][Full Text] [Related]
9. Domain cross-talk in regulation of histone modifications: Molecular mechanisms and targeting opportunities.
Longbotham JE; Zhang MY; Fujimori DG
Curr Opin Chem Biol; 2020 Aug; 57():105-113. PubMed ID: 32758979
[TBL] [Abstract][Full Text] [Related]
10. Combined Action of Histone Reader Modules Regulates NuA4 Local Acetyltransferase Function but Not Its Recruitment on the Genome.
Steunou AL; Cramet M; Rossetto D; Aristizabal MJ; Lacoste N; Drouin S; Côté V; Paquet E; Utley RT; Krogan N; Robert F; Kobor MS; Côté J
Mol Cell Biol; 2016 Nov; 36(22):2768-2781. PubMed ID: 27550811
[TBL] [Abstract][Full Text] [Related]
11. BET Bromodomain as a Target of Epigenetic Therapy.
Noguchi-Yachide T
Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
[TBL] [Abstract][Full Text] [Related]
12. Targeting Epigenetics in Cancer.
Bennett RL; Licht JD
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():187-207. PubMed ID: 28992434
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the development of peptide-based inhibitors targeting epigenetic readers of histone lysine acetylation and methylation marks.
Liu S; Li X; Li X; Li XD
Curr Opin Chem Biol; 2023 Aug; 75():102334. PubMed ID: 37263048
[TBL] [Abstract][Full Text] [Related]
14. Chromatin condensation and recruitment of PHD finger proteins to histone H3K4me3 are mutually exclusive.
Gatchalian J; Gallardo CM; Shinsky SA; Ospina RR; Liendo AM; Krajewski K; Klein BJ; Andrews FH; Strahl BD; M van Wely KH; Kutateladze TG
Nucleic Acids Res; 2016 Jul; 44(13):6102-12. PubMed ID: 27016734
[TBL] [Abstract][Full Text] [Related]
15. Reading More than Histones: The Prevalence of Nucleic Acid Binding among Reader Domains.
Weaver TM; Morrison EA; Musselman CA
Molecules; 2018 Oct; 23(10):. PubMed ID: 30322003
[TBL] [Abstract][Full Text] [Related]
16. Biological role and mechanism of chromatin readers in plants.
Scheid R; Chen J; Zhong X
Curr Opin Plant Biol; 2021 Jun; 61():102008. PubMed ID: 33581373
[TBL] [Abstract][Full Text] [Related]
17. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.
Vermeulen M; Eberl HC; Matarese F; Marks H; Denissov S; Butter F; Lee KK; Olsen JV; Hyman AA; Stunnenberg HG; Mann M
Cell; 2010 Sep; 142(6):967-80. PubMed ID: 20850016
[TBL] [Abstract][Full Text] [Related]
18. Coordinated methyl readers: Functional communications in cancer.
Park IG; Jeon M; Kim H; Lee JM
Semin Cancer Biol; 2022 Aug; 83():88-99. PubMed ID: 33753223
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
20. Dual recognition of H3K4me3 and H3K27me3 by a plant histone reader SHL.
Qian S; Lv X; Scheid RN; Lu L; Yang Z; Chen W; Liu R; Boersma MD; Denu JM; Zhong X; Du J
Nat Commun; 2018 Jun; 9(1):2425. PubMed ID: 29930355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
